Latest filing published 19 Sept 2023 for Adamis Pharmaceuticals Corp.
Insider track record
No signal scores available.
Ebrahim Versi: trading record in brief
Ebrahim Versi discloses dealings in Adamis Pharmaceuticals Corp to SEC (Form 4). Between 25 May 2023 and 15 September 2023, the trades on record add up to 3 filings.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
The newest entry dates from 19 September 2023: a transaction, in Adamis Pharmaceuticals Corp. The median gap between a trade and its publication by SEC (Form 4) is 5 days. The legal deadline for a Form 4 is two business days after the transaction. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.
Companies and markets linked to Ebrahim Versi
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 729,200 shares0Common StockSEC:0001387131-23-011359:0
- 8,745 sharesCommon StockSEC:0001839882-23-013976:0
- 177,194 sharesCommon StockSEC:0001839882-23-013976:1
3 of 3 declarations